Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Lohmann

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Archives of Pathology & Laboratory Medicine|September 1, 1989
Reliability of white blood cell countingR C Lohmann, D E Wood, W I Jacobs, et al.
Canadian Medical Association Journal|December 1, 1984
Plasma exchange in thrombotic thrombocytopenic purpuraE B Toffelmire, W F Clark, P E Cordy, et al.
Canadian Medical Association Journal|June 10, 1978
Immunologic findings, thrombocytopenia and disease activity in lupus nephritisW F Clark, A L Linton, P E Cordy, et al.
Annals of Plastic Surgery|November 25, 2000
Sentinel node biopsy in melanoma using technetium-99m rhenium colloid: the London experienceC L Temple, C G Scilley, C J Engel, et al.
Investigational New Drugs|November 27, 2002
A randomized phase II study of two schedules of bryostatin-1 (NSC339555) in patients with advanced malignant melanoma: A National Cancer Institute of Canada Clinical Trials Group studyR G Tozer, S Burdette-Radoux, K Berlanger, et al.
Journal of Surgical Oncology|January 16, 2007
Clinical significance of the RT-PCR positive sentinel node in melanomaC L F Temple, L J Snell, S M Power, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. National Cancer Institute of Canada Clinical Trials GroupJ J Rusthoven, I C Quirt, N A Iscoe, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Archives of Pathology & Laboratory Medicine|September 1, 1989
Reliability of white blood cell countingR C Lohmann, D E Wood, W I Jacobs, et al.
Canadian Medical Association Journal|December 1, 1984
Plasma exchange in thrombotic thrombocytopenic purpuraE B Toffelmire, W F Clark, P E Cordy, et al.
Canadian Medical Association Journal|June 10, 1978
Immunologic findings, thrombocytopenia and disease activity in lupus nephritisW F Clark, A L Linton, P E Cordy, et al.
Annals of Plastic Surgery|November 25, 2000
Sentinel node biopsy in melanoma using technetium-99m rhenium colloid: the London experienceC L Temple, C G Scilley, C J Engel, et al.
Investigational New Drugs|November 27, 2002
A randomized phase II study of two schedules of bryostatin-1 (NSC339555) in patients with advanced malignant melanoma: A National Cancer Institute of Canada Clinical Trials Group studyR G Tozer, S Burdette-Radoux, K Berlanger, et al.
Journal of Surgical Oncology|January 16, 2007
Clinical significance of the RT-PCR positive sentinel node in melanomaC L F Temple, L J Snell, S M Power, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. National Cancer Institute of Canada Clinical Trials GroupJ J Rusthoven, I C Quirt, N A Iscoe, et al.
Pageof 2